Sustainability & Climate

Coway updates its iconic Airmega Mighty. With new smarts and a sleek design, can the Mighty2 fend off fierce rivals in a market hungry for clean air?

A new study reveals a massive shift in retirement strategy, as economic pressures and a desire for purpose lead Americans to embrace a more fluid future.

The man who scaled ASOS to a global giant now joins Kornit Digital to help dismantle the old supply chain and build a sustainable, on-demand future.

Amid a growing need for connection, a national call for hospice volunteers highlights the profound benefits for both patients and the givers themselves.

Biotech firm Humacyte raises $20M to accelerate sales of its FDA-approved Symvess® and fund crucial trials for new hemodialysis applications.

A novel drug designed to eliminate stubborn cancer proteins enters human trials, offering a new strategy for ALK+ lung cancer patients facing resistance.

With pivotal trials advancing, key FDA alignment, and a strong cash position, Taysha Gene Therapies charts a clear path toward a potential breakthrough.

Following its 2024 acquisition, Hillcore Industrial promotes CEDA’s CEO and CFO to lead its entire portfolio, signaling a major strategic integration.

ImmunoBrain's novel immunotherapy for Alzheimer's avoids key safety issues of other drugs and shows positive biomarker data in a Phase 1b trial.

Amidst record sales but widening losses, the Vietnamese automaker is overhauling its strategy, betting on smart factories and AI to carve out a profitable future.

A new app feature aims to combat costly workplace loneliness, but can a digital platform truly solve a deeply human problem of disconnection?

Endevica Bio launches Kalohexis, a new biotech aiming to disrupt the obesity market with a drug that resets the body's 'metabolic thermostat'.

The toy giant's 600,000-square-foot facility is more than a warehouse; it's a key move in its plan for faster delivery and supply chain dominance.

A new drug shows unprecedented activity against all common cold viruses, a major breakthrough for millions suffering from chronic lung diseases.

An upcoming webinar aims to move beyond polarized debates, exploring the future of scientific testing as public support wanes and new technologies emerge.

A new $7 million deal will use a digital marketplace to deliver 16 million doses of a life-saving antibiotic to children in Burkina Faso. But can it work?

Belief BioMed's single-dose treatment for hemophilia B, BBM-H901, is now approved in Macao, offering a new horizon for patients beyond frequent injections.

Lassila & Tikanoja charts a stable future with a long-term CEO succession plan, following a major strategic pivot to a pure-play circular economy company.

Following positive study results, BioPorto is moving its NGAL test for adult acute kidney injury toward FDA review, aiming to revolutionize early detection.

A Peoria family of five will finally get relief from skin irritation and the cost of bottled water after winning a home water system from Parker & Sons.